Advances in glaucoma treatment and management: outflow drugs.
作者信息
Kaufman Paul L, Rasmussen Carol A
机构信息
Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin 53705-2135, USA.
出版信息
Invest Ophthalmol Vis Sci. 2012 May 4;53(5):2495-500. doi: 10.1167/iovs.12-9483m.
Abstract
摘要
相似文献
1
Advances in glaucoma treatment and management: outflow drugs.青光眼治疗与管理的进展：引流药物
Invest Ophthalmol Vis Sci. 2012 May 4;53(5):2495-500. doi: 10.1167/iovs.12-9483m.
2
Advances in glaucoma diagnosis and therapy for the next millennium: new drugs for trabecular and uveoscleral outflow.下一个千年青光眼诊断与治疗的进展：用于小梁网和葡萄膜巩膜途径引流的新药
Semin Ophthalmol. 1999 Sep;14(3):130-43. doi: 10.3109/08820539909061466.
3
Effects of prostaglandins on the aqueous humor outflow pathways.前列腺素对房水流出途径的影响。
Surv Ophthalmol. 2002 Aug;47 Suppl 1:S53-64. doi: 10.1016/s0039-6257(02)00306-5.
4
Nitric oxide: a drug target for glaucoma revisited.一氧化氮：重新审视青光眼的药物靶点。
Drug Discov Today. 2019 Aug;24(8):1614-1620. doi: 10.1016/j.drudis.2019.05.033. Epub 2019 Jun 4.
5
Pressure dependence of uveoscleral outflow.葡萄膜巩膜外流的压力依赖性
J Glaucoma. 2002 Oct;11(5):464. doi: 10.1097/00061198-200210000-00017.
6
Pressure dependence of uveoscleral outflow.葡萄膜巩膜流出的压力依赖性。
J Glaucoma. 2002 Dec;11(6):545. doi: 10.1097/00061198-200212000-00019.
7
NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs.NCX 470 比卢美根更有效地降低犬眼内压，并增强非人类灵长类动物和人眼小梁网/施莱姆氏管结构的传统和葡萄膜巩膜流出。
J Ocul Pharmacol Ther. 2024 Jul-Aug;40(6):389-396. doi: 10.1089/jop.2023.0102. Epub 2023 Dec 12.
8
Seeing is believing: NO therapy for glaucoma? Focus on "Role of nitric oxide in murine conventional outflow physiology".眼见为实：青光眼无治疗方法？聚焦于“一氧化氮在小鼠传统房水流出生理中的作用”
Am J Physiol Cell Physiol. 2015 Aug 15;309(4):C203-4. doi: 10.1152/ajpcell.00180.2015. Epub 2015 Jun 24.
9
Direct involvement of trabecular meshwork in the regulation of aqueous humor outflow.小梁网直接参与房水流出的调节。
Curr Opin Ophthalmol. 1998 Apr;9(2):46-9. doi: 10.1097/00055735-199804000-00009.
10
Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, following the trail.通过破坏肌动蛋白细胞骨架来增强小梁网房水流出、使用前列腺素增加葡萄膜巩膜房水流出，以及探究老花眼的病理生理学——向大自然发问：问为什么，问如何，识别迹象，循迹追踪。
Exp Eye Res. 2008 Jan;86(1):3-17. doi: 10.1016/j.exer.2007.10.007. Epub 2007 Oct 26.
引用本文的文献
1
The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practice.内源性大麻素系统与眼科疾病：分子机制综述及其对临床实践的启示
Front Med (Lausanne). 2025 Feb 5;12:1500179. doi: 10.3389/fmed.2025.1500179. eCollection 2025.
2
Simulation of gravity- and pump-driven perfusion techniques for measuring outflow facility of ex vivo and in vivo eyes.模拟重力和泵驱动灌注技术测量离体和在体眼流出道通畅性。
PLoS One. 2023 Nov 21;18(11):e0294607. doi: 10.1371/journal.pone.0294607. eCollection 2023.
3
Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma.垂体腺苷酸环化酶激活肽对中度青光眼大鼠视网膜血管和分子反应的保护作用。
Int J Mol Sci. 2023 Aug 26;24(17):13256. doi: 10.3390/ijms241713256.
4
Recreating the Trabecular Outflow Tissue on Implantable, Micropatterned, Ultrathin, Porous Polycaprolactone Scaffolds.在可植入的、微图案化的、超薄的、多孔聚己内酯支架上重建小梁流出组织。
Bioengineering (Basel). 2023 Jun 2;10(6):679. doi: 10.3390/bioengineering10060679.
5
Fluoxetine Protects Retinal Ischemic Damage in Mice.氟西汀可保护小鼠视网膜缺血性损伤。
Pharmaceutics. 2023 Apr 29;15(5):1370. doi: 10.3390/pharmaceutics15051370.
6
Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery.机器学习驱动的多功能肽工程用于持续眼部药物输送。
Nat Commun. 2023 May 2;14(1):2509. doi: 10.1038/s41467-023-38056-w.
7
A novel glaucoma approach: Stem cell regeneration of the trabecular meshwork.一种新的青光眼治疗方法：小梁网干细胞再生。
Prog Retin Eye Res. 2022 Sep;90:101063. doi: 10.1016/j.preteyeres.2022.101063. Epub 2022 Apr 6.
8
A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma.关于新型眼部给药系统的综述，重点关注青光眼
Adv Pharm Bull. 2021 May;11(3):399-413. doi: 10.34172/apb.2021.048. Epub 2020 Sep 19.
9
Retinoprotective Effects of PACAP Eye Drops in Microbead-Induced Glaucoma Model in Rats.PACAP 滴眼液对大鼠微珠诱导性青光眼模型的视网膜保护作用。
Int J Mol Sci. 2021 Aug 17;22(16):8825. doi: 10.3390/ijms22168825.
10
Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells.离子复合微晶制剂可从结膜下间隙持续递送多模态激酶抑制剂以保护视网膜神经节细胞。
Pharmaceutics. 2021 May 1;13(5):647. doi: 10.3390/pharmaceutics13050647.
本文引用的文献
1
eNOS, a pressure-dependent regulator of intraocular pressure.内皮型一氧化氮合酶（eNOS），一种眼压的压力依赖性调节因子。
Invest Ophthalmol Vis Sci. 2011 Dec 9;52(13):9438-44. doi: 10.1167/iovs.11-7839.
2
Kappa opioid receptor localization and coupling to nitric oxide production in cells of the anterior chamber.前房细胞中 κ 阿片受体的定位和与一氧化氮产生的偶联。
Invest Ophthalmol Vis Sci. 2011 Jul 13;52(8):5233-9. doi: 10.1167/iovs.10-6613.
3
Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.BOL-303259-X，一种一氧化氮供体前列腺素 F2α 激动剂，在临床前模型中的降眼压活性。
Exp Eye Res. 2011 Sep;93(3):250-5. doi: 10.1016/j.exer.2011.03.001. Epub 2011 Mar 9.
4
The role of the prostaglandin EP4 receptor in the regulation of human outflow facility.前列腺素 EP4 受体在人房水流出机制调节中的作用。
Invest Ophthalmol Vis Sci. 2011 Jun 1;52(6):3506-13. doi: 10.1167/iovs.10-6510.
5
Focus on molecules: SFRP1.聚焦分子：分泌型卷曲相关蛋白1
Exp Eye Res. 2010 Nov;91(5):552-3. doi: 10.1016/j.exer.2010.05.003. Epub 2010 May 15.
6
Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma.开发一种携带糖皮质激素诱导型 MMP1 的基因治疗病毒，用于治疗类固醇性青光眼。
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3029-41. doi: 10.1167/iovs.09-4918. Epub 2010 Jan 20.
7
COCH transgene expression in cultured human trabecular meshwork cells and its effect on outflow facility in monkey organ cultured anterior segments.在培养的人眼小梁细胞中的 COCH 转基因表达及其对猴眼器官培养前段流出道通畅性的影响。
Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2060-6. doi: 10.1167/iovs.09-4521. Epub 2009 Nov 20.
8
Identification of lymphatics in the ciliary body of the human eye: a novel "uveolymphatic" outflow pathway.人眼睫状体中的淋巴管鉴定：一种新的“葡萄膜淋巴”流出途径。
Exp Eye Res. 2009 Nov;89(5):810-9. doi: 10.1016/j.exer.2009.08.010. Epub 2009 Sep 1.
9
Self-complementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys.自互补型腺相关病毒（scAAV）在活体大鼠和猴子的小梁网中安全且长期的基因转移。
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):236-48. doi: 10.1167/iovs.09-3847. Epub 2009 Aug 13.
10
Regulation of cross-linked actin network (CLAN) formation in human trabecular meshwork (HTM) cells by convergence of distinct beta1 and beta3 integrin pathways.通过不同的β1和β3整合素途径汇聚对人小梁网（HTM）细胞中交联肌动蛋白网络（CLAN）形成的调节
Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5723-31. doi: 10.1167/iovs.08-3215. Epub 2009 Jul 30.
Zotero 插件